Is Fidelity Select Biotechnology (FBIOX) a Strong Mutual Fund Pick Right Now?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 12 2024
0mins
Source: NASDAQ.COM
Fidelity Select Biotechnology Fund Overview: Fidelity Select Biotechnology (FBIOX) is a Sector - Health mutual fund with a Zacks Mutual Fund Rank of 1 (Strong Buy), but it has shown weak performance with a 5-year annualized return of 7.03% and a negative 3-year return of -2.98%.
Cost and Volatility Analysis: FBIOX has a lower expense ratio of 0.71% compared to the category average, making it cost-effective; however, it exhibits higher volatility with a standard deviation above its peers, and a negative alpha indicating difficulty in outperforming the S&P 500 benchmark.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
